Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era

SIMPLE SUMMARY: The potential interference at the immune response level between COVID-19 and cancer therapy raises key clinical questions and points out scientific issues that need to be promptly addressed. Among the therapeutic strategies available in oncological clinics, major concerns are raised...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Burgaletto, Chiara, Brunetti, Oronzo, Munafò, Antonio, Bernardini, Renato, Silvestris, Nicola, Cantarella, Giuseppina, Argentiero, Antonella
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2021
Gaiak:
Opinion
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8071446/
https://ncbi.nlm.nih.gov/pubmed/33921021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13081906
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak